<SEC-DOCUMENT>0001797199-20-000005.txt : 20201116
<SEC-HEADER>0001797199-20-000005.hdr.sgml : 20201116
<ACCEPTANCE-DATETIME>20201116200645
ACCESSION NUMBER:		0001797199-20-000005
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201112
FILED AS OF DATE:		20201116
DATE AS OF CHANGE:		20201116

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GORENSTEIN MICHAEL RYAN
		CENTRAL INDEX KEY:			0001797199

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		201318999

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET, SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2G9

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2G9
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2G9

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_160557518838656.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2020-11-12</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001656472</issuerCik>
        <issuerName>Cronos Group Inc.</issuerName>
        <issuerTradingSymbol>CRON</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001797199</rptOwnerCik>
            <rptOwnerName>GORENSTEIN MICHAEL RYAN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>111 PETER STREET, SUITE 300</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>TORONTO</rptOwnerCity>
            <rptOwnerState>A6</rptOwnerState>
            <rptOwnerZipCode>M5V 2G9</rptOwnerZipCode>
            <rptOwnerStateDescription>ONTARIO, CANADA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Chairman</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>COMMON SHARES</value>
            </securityTitle>
            <transactionDate>
                <value>2020-11-12</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>4000000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.1876</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4617447</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>COMMON SHARES</value>
            </securityTitle>
            <transactionDate>
                <value>2020-11-12</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>F</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F2"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>105151</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>7.14</value>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4512296</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>WARRANTS</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.1876</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2020-11-12</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>4000000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2021-05-27</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>COMMON SHARES</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4000000.0</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3990221</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The price reported was converted from the Canadian exercise price of C$0.245 to U.S. dollars using an exchange rate of C$1.00 to US$0.7657 as reported by Bloomberg as of November 11, 2020.</footnote>
        <footnote id="F2">On November 12, 2020, the reporting person exercised warrants to purchase 4,000,000 common shares of Cronos Group Inc. (the &quot;Company&quot;) for C$0.245 per common share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 105,151 common shares to pay the exercise price and issuing to the reporting person the remaining 3,894,849 common shares.</footnote>
        <footnote id="F3">The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7657 as reported by Bloomberg as of November 11, 2020.</footnote>
        <footnote id="F4">The warrants were issued between May 16, 2016 and August 12, 2016 and were immediately exercisable.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein</signatureName>
        <signatureDate>2020-11-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
